FDA inspection
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site): FDA inspection ending Nov 21, 2008
FDA inspection 552585 · Voluntary Action Indicated (VAI) · Hanzhong
Key facts
| Inspection ID | 552585 |
|---|---|
| Firm | Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) |
| FEI number | 3003011617 |
| Address | North Of Hanzhong, No 103 Yaochang Road; Hantai District |
| City | Hanzhong |
| Country | China |
| Fiscal year | 2009 |
| Inspection end date | Nov 21, 2008 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data